Mitomycin C‐immobilized silver nanoparticle‐loaded polycaprolactone membrane for temporary scalp expansion after decompressive craniectomy to prevent wound infection

IF 6.1 2区 医学 Q1 ENGINEERING, BIOMEDICAL
Kai‐Lun Liu, Ya‐Jyun Liang, Kuo‐Hsiang Hung, Yu‐Ning Chen, Feng‐Huei Lin
{"title":"Mitomycin C‐immobilized silver nanoparticle‐loaded polycaprolactone membrane for temporary scalp expansion after decompressive craniectomy to prevent wound infection","authors":"Kai‐Lun Liu, Ya‐Jyun Liang, Kuo‐Hsiang Hung, Yu‐Ning Chen, Feng‐Huei Lin","doi":"10.1002/btm2.70023","DOIUrl":null,"url":null,"abstract":"Malignant cerebral edema (MCE) represents a significant medical emergency characterized by unmanageable intracranial pressure (ICP), frequently arising as a consequence of traumatic brain injury (TBI) or ischemic stroke. Decompressive craniectomy (DC) is a prevalent surgical procedure employed to mitigate elevated ICP by excising a segment of the skull to enhance intracranial volume. Nevertheless, in patients suffering from MCE, the limited capacity for expansion of the scalp subsequent to DC may lead to sustained elevated ICP and complications including wound‐edge necrosis, cerebrospinal fluid leakage, and infection. This investigation seeks to formulate a biocompatible, antibacterial, and anti‐adhesive membrane intended for temporary scalp expansion following DC, thereby addressing these pressing concerns. The proposed membrane comprises polycaprolactone (PCL) augmented with silver nanoparticles (AgNPs) to confer antibacterial properties and is further immobilized with Mitomycin C (MMC) to minimize tissue adhesion, thereby facilitating more straightforward removal. The selection of PCL was predicated upon its remarkable mechanical strength and ductility, which make it suitable for withstanding intracranial edema and facilitating the suturing protocol. The AgNPs were synthesized through a green synthesis methodology employing epigallocatechin gallate (EGCG) to ensure environmental sustainability and the stability of the resultant nanoparticles. MMC, known for its anti‐proliferative attributes, was affixed to the PCL surface via oxygen plasma treatment, thereby enhancing the anti‐adhesive properties of the membrane. This study evaluates the mechanical characteristics, antibacterial effectiveness, anti‐adhesive capabilities, and biocompatibility of the PCL/AgNPs/MMC membrane, thereby demonstrating its potential to improve outcomes in DC procedures by increasing intracranial volume and reducing postoperative complications.","PeriodicalId":9263,"journal":{"name":"Bioengineering & Translational Medicine","volume":"87 1","pages":""},"PeriodicalIF":6.1000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering & Translational Medicine","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1002/btm2.70023","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Malignant cerebral edema (MCE) represents a significant medical emergency characterized by unmanageable intracranial pressure (ICP), frequently arising as a consequence of traumatic brain injury (TBI) or ischemic stroke. Decompressive craniectomy (DC) is a prevalent surgical procedure employed to mitigate elevated ICP by excising a segment of the skull to enhance intracranial volume. Nevertheless, in patients suffering from MCE, the limited capacity for expansion of the scalp subsequent to DC may lead to sustained elevated ICP and complications including wound‐edge necrosis, cerebrospinal fluid leakage, and infection. This investigation seeks to formulate a biocompatible, antibacterial, and anti‐adhesive membrane intended for temporary scalp expansion following DC, thereby addressing these pressing concerns. The proposed membrane comprises polycaprolactone (PCL) augmented with silver nanoparticles (AgNPs) to confer antibacterial properties and is further immobilized with Mitomycin C (MMC) to minimize tissue adhesion, thereby facilitating more straightforward removal. The selection of PCL was predicated upon its remarkable mechanical strength and ductility, which make it suitable for withstanding intracranial edema and facilitating the suturing protocol. The AgNPs were synthesized through a green synthesis methodology employing epigallocatechin gallate (EGCG) to ensure environmental sustainability and the stability of the resultant nanoparticles. MMC, known for its anti‐proliferative attributes, was affixed to the PCL surface via oxygen plasma treatment, thereby enhancing the anti‐adhesive properties of the membrane. This study evaluates the mechanical characteristics, antibacterial effectiveness, anti‐adhesive capabilities, and biocompatibility of the PCL/AgNPs/MMC membrane, thereby demonstrating its potential to improve outcomes in DC procedures by increasing intracranial volume and reducing postoperative complications.
丝裂霉素C固定化载银纳米颗粒聚己内酯膜用于颅骨减压术后临时头皮扩张以防止伤口感染
恶性脑水肿(MCE)是一种以难以控制的颅内压(ICP)为特征的重大医疗紧急情况,通常由创伤性脑损伤(TBI)或缺血性中风引起。减压颅骨切除术(DC)是一种常用的外科手术,通过切除颅骨的一段来增加颅内容量来减轻颅内压升高。然而,在MCE患者中,DC后头皮扩张能力有限可能导致持续的颅内压升高和并发症,包括伤口边缘坏死、脑脊液漏和感染。本研究旨在制备一种生物相容性、抗菌性和抗粘附性的膜,用于DC后的暂时性头皮扩张,从而解决这些紧迫的问题。所提出的膜由聚己内酯(PCL)和银纳米颗粒(AgNPs)增强以赋予抗菌性能,并进一步用丝裂霉素C (MMC)固定以减少组织粘附,从而促进更直接的去除。选择PCL是基于其卓越的机械强度和延展性,使其适合承受颅内水肿,便于缝合方案。AgNPs通过绿色合成方法合成,采用表没食子儿茶素没食子酸酯(EGCG),以确保环境可持续性和合成纳米颗粒的稳定性。MMC以其抗增殖特性而闻名,通过氧等离子体处理附着在PCL表面,从而增强了膜的抗粘附性能。本研究评估了PCL/AgNPs/MMC膜的机械特性、抗菌效果、抗粘附能力和生物相容性,从而证明其通过增加颅内容量和减少术后并发症来改善DC手术结果的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bioengineering & Translational Medicine
Bioengineering & Translational Medicine Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
8.40
自引率
4.10%
发文量
150
审稿时长
12 weeks
期刊介绍: Bioengineering & Translational Medicine, an official, peer-reviewed online open-access journal of the American Institute of Chemical Engineers (AIChE) and the Society for Biological Engineering (SBE), focuses on how chemical and biological engineering approaches drive innovative technologies and solutions that impact clinical practice and commercial healthcare products.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信